Riskpilot← Back to searchSign inGet full accessADUMED ApS
APSActiveCVR 41975989Kirkeplads 8Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20201 employeeswww.adumed.com
Revenue 2025
—
EBITDA margin
—
Equity ratio
64.6%
Financial strength
Net profit 2025
DKK 2
+100% vs 2024
| Revenue | — | — |
| EBITDA | DKK 0 | — |
| Net profit | DKK 2 | +100% |
| Total assets | DKK 923K | +433% |
| Equity | DKK 596K | +264% |
| Employees | 1 | — |
Legal name
ADUMED ApS
CVR number
41975989
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20. december 2020
Share capital
DKK 1.000.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren
Company purpose
Selskabets formål er at producere og drive handel med hospitals- og sygeplejeartikler samt al virksomhed, som efter ledelsens skøn er beslægtet hermed
Address
Kirkeplads 8
Phone
+4530580398
Email
lbd@adumed.com
Website
www.adumed.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | -46 | -48 | -1 | — |
| Staff expenses | -0 | -202 | -52 | -0 | -0 |
| EBITDA | 0 | -340 | -138 | -1 | 0 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 0 | -340 | -138 | -1 | 0 |
| Net financials | 0 | -0 | -0 | 0 | 0 |
| Profit before tax | 0 | -340 | -138 | -0 | 0 |
| Tax | -0 | -75 | -0 | -0 | -0 |
| Net profit | 0 | -265 | -138 | -0 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 40 | 555 | 157 | 173 | 923 |
| Equity | 40 | -225 | -363 | -364 | 596 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 780 | 520 | 537 | 327 |
| Total debt | 0 | 780 | 520 | 537 | 327 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212025
Equity ratio
64.6%
This company
38.2%
Market median
+69% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
200.0%
This company
8.1%
Market median
+2369% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-12-20 – 2021-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JB Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
LB Founder | Founder | 2020 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Sandvig Capital ApS | Company | 100.0% | 100.0% | 2025 |
Mikkel B. Denker ApS | Company | 10.0% | 10.0% | 2020 |
Magnus B. Denker ApS | Company | 10.0% | 10.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JBD, Aabenraa ApS
ADUMED ApS Board members of ADUMED ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jeannette Buchard Denker | Chief Executive Officer | 0 companies |
| Lars Buchard Denker | Founder | 0 companies |